» Articles » PMID: 16284945

Diabetes Mellitus and Cancer Risk in a Population-based Case-control Study Among Men from Montreal, Canada

Overview
Journal Int J Cancer
Specialty Oncology
Date 2005 Nov 15
PMID 16284945
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetics may have a higher risk of cancer, notably liver and pancreatic cancers. Evidence about other cancer types remains sparse. The authors examined potential associations between diabetes and several types of cancer in a large multicancer case-control project carried out in Montreal, Canada, in the 1980s. This report, based on 3,107 male cancer cases and 509 population controls, uses information on diabetes and several covariates collected by interview. Adjusted odds ratios (ORs) and 95% confidence intervals (CI) were estimated for the associations between diabetes and each of 12 cancer types. Risks of pancreatic and liver cancers were increased among diabetics: adjusted ORs were 2.1 (95% CI: 1.0, 4.3) for pancreatic and 3.1 (95% CI: 1.1, 8.8) for liver cancer. The increased risk of pancreatic cancer was completely restricted to those with recent onset of diabetes; this was likely a manifestation of reverse causality. Conversely, the increased risk of liver cancer was independent of the interval between diabetes and cancer diagnoses. No associations were observed with melanoma, non-Hodgkin's lymphoma, cancers of the esophagus, stomach, colon, rectum, lung, prostate, bladder and kidney. In conclusion, diabetes was associated with an increased risk of liver cancer among men, but with no other cancer type including pancreatic cancer.

Citing Articles

Highly active selenium nanotherapeutics combined with metformin to achieve synergistic sensitizing effect on NK cells for osteosarcoma therapy.

Du Y, Zhang Z, Yang Y, Liu T, Chen T, Li X Nanophotonics. 2024; 11(22):5101-5111.

PMID: 39634308 PMC: 11501141. DOI: 10.1515/nanoph-2022-0289.


Deciphering the Precise Target for Saroglitazar Associated Antiangiogenic Effect: A Computational Synergistic Approach.

Dabral S, Khan I, Pant T, Khan S, Prakash P, Parvez S ACS Omega. 2023; 8(17):14985-15002.

PMID: 37151537 PMC: 10157850. DOI: 10.1021/acsomega.2c07570.


Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions.

Cheng T, Bai Y, Huang S, Wang Y, Zhou S, Liu H J Gastrointest Oncol. 2022; 13(5):2485-2496.

PMID: 36388662 PMC: 9660067. DOI: 10.21037/jgo-22-825.


The Association between the Risk of Esophageal Cancer and Type 2 Diabetes Mellitus: An Updated Meta-Analysis.

Zhou R, Huang C, Luo Z, Wang T Biomed Res Int. 2022; 2022:8129771.

PMID: 36277883 PMC: 9584674. DOI: 10.1155/2022/8129771.


Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care.

Dobbie L, Kassab M, Davison A, Grace P, Cuthbertson D, Hydes T J Clin Med. 2021; 10(24).

PMID: 34945051 PMC: 8706667. DOI: 10.3390/jcm10245755.